John Tarplee is President of the UK Communications capability and part of the leadership of Lumanity’s Medical Strategy and Communications global practice. John is responsible for ensuring the successful development and implementation of all Lumanity’s medical and scientific communications activities conducted from the UK. Additionally, as part of the Medical Strategy and Communications global practice leadership team, John works to continuously develop strategies, services and products to realize the global vision and mission of Lumanity and support our clients in realizing their goals.
Before taking up his current role, John worked as a senior client-facing strategy consultant within Lumanity’s Asset Optimization and Commercialization Global practice. John had responsibility for several large global client relationships and led commercial strategy engagements, helping a range of clients answer difficult challenges in order to inform strategic decision making.
Prior to that John spent over 30 years in large multinational pharma organizations as well as small specialty biopharma companies, culminating in commercial leadership roles across Europe and Asia.